[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=e500c9d126125cf1fe955393f1aff0e0a20d8628ace0d11748824a413e5473ee",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746204180,
      "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 134276137,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=e500c9d126125cf1fe955393f1aff0e0a20d8628ace0d11748824a413e5473ee"
    }
  },
  {
    "ts": null,
    "headline": "Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y",
    "summary": "ALNY reports better-than-expected first-quarter results as both earnings and revenues beat estimates, driven by higher product sales.",
    "url": "https://finnhub.io/api/news?id=03113cf0312832ad7c80c0a0d349d3e060341e5cd87fd998ee81d2cc7bdabdac",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746197460,
      "headline": "Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y",
      "id": 134204575,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "ALNY reports better-than-expected first-quarter results as both earnings and revenues beat estimates, driven by higher product sales.",
      "url": "https://finnhub.io/api/news?id=03113cf0312832ad7c80c0a0d349d3e060341e5cd87fd998ee81d2cc7bdabdac"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals - Dupixent Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases",
    "summary": "TARRYTOWN - Regeneron Pharmaceuticals, Inc. announced 24 abstracts on Dupixent clinical data and real-world analyses in respiratory diseases will be presented at the American Thoracic Society ...",
    "url": "https://finnhub.io/api/news?id=572a8eba2a671abdc48daafe63341b21c4f7692684e77c89b38c894816b71eb8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746176808,
      "headline": "Regeneron Pharmaceuticals - Dupixent Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases",
      "id": 134183833,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "TARRYTOWN - Regeneron Pharmaceuticals, Inc. announced 24 abstracts on Dupixent clinical data and real-world analyses in respiratory diseases will be presented at the American Thoracic Society ...",
      "url": "https://finnhub.io/api/news?id=572a8eba2a671abdc48daafe63341b21c4f7692684e77c89b38c894816b71eb8"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo CSCC Updates and Promising Early Blood Cancer Data with Linvoseltamab Combination",
    "summary": "TARRYTOWN - Regeneron Pharmaceuticals, Inc. announced new and updated data from its oncology and hematology portfolio will be shared at the 2025 American Society of Clinical Oncology Annual Meeting,...",
    "url": "https://finnhub.io/api/news?id=55a07e8a4e85f9753d0f345a6cf9774e0dab6f78575042e760843289278636fa",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746176806,
      "headline": "Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo CSCC Updates and Promising Early Blood Cancer Data with Linvoseltamab Combination",
      "id": 134183836,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "TARRYTOWN - Regeneron Pharmaceuticals, Inc. announced new and updated data from its oncology and hematology portfolio will be shared at the 2025 American Society of Clinical Oncology Annual Meeting,...",
      "url": "https://finnhub.io/api/news?id=55a07e8a4e85f9753d0f345a6cf9774e0dab6f78575042e760843289278636fa"
    }
  }
]